Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - FHT-1015

FHT-1015

CAS No. 2368903-18-6

FHT-1015( —— )

Catalog No. M35753 CAS No. 2368903-18-6

FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	149	In Stock
5MG	123	In Stock
10MG	205	In Stock
25MG	395	In Stock
50MG	631	In Stock
100MG	1004	In Stock
200MG	1358	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

FHT-1015
Note

Research use only, not for human use.
Brief Description

FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.
Description

FHT-1205 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC50s of ≤10 nM (WO2020160180A1; compound 67).
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Chromatin/Epigenetic
Target

Epigenetic Reader Domain
Recptor

Epigenetic Reader Domain
Research Area

——
Indication

——

Chemical Information

CAS Number

2368903-18-6
Formula Weight

555.69
Molecular Formula

C25H25N5O4S3
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : ≥ 100 mg/mL (179.96 mM )
SMILES

CSCC[C@H](NC(=O)c1ccn(c1)S(C)(=O)=O)C(=O)Nc1nc(cs1)-c1cccc(c1)-c1ccncc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Rishi G. Vaswani, et al. Compounds and uses thereof. WO2020160180A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BAZ1A-IN-1

BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.
BRM/BRG1 ATP Inhibit...

BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
Dihydroactinidiolide

Dihydroactinidiolideis avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance.

Sign In Join Free